Research
Molecular
Small molecule agonists of GLP-1 receptor have advantages of low cost and oral administration compared to peptide drugs.
Practitioners may consider small molecule GLP-1 receptor agonists as a cost-effective and convenient treatment option.
StrongSupportsmedium confidence
Compared with peptide drugs, small molecule agonists have the advantages of low cost and oral administration.
Why this rating
The claim is based on a review of recent research progress.
Source
The Discovery and Development of Glucagon-Like Peptide-1Receptor Agonists
Haowen Fang et al. · Current Medicinal Chemistry · 2023
DOI 10.2174/0929867330666230416153301
reviewCited 2×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Molecular
- QRISK decreased markedly after weight loss from 18.9 ± 2.2% to 11.2 ± 1.6%, p < 0.0001.Strong
- Normalization of 10-year cardiovascular risk and heart age is possible after substantial dietary weight loss and remission of T2DM.Strong
- The Low-Fat Plus diet resulted in a greater reduction in total cholesterol compared to the Low-Fat diet, with changes of -0.46 mmol/L (-17.6 mg/dL) versus -0.24 mmol/L (-9.2 mg/dL) respectively (P = 0.01).Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →